Search Results

There are 23455 results for: content related to: Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo

  1. You have free access to this content
    Nicotine receptor partial agonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Kate Cahill, Nicola Lindson-Hawley, Kyla H Thomas, Thomas R Fanshawe and Tim Lancaster

    Published Online : 9 MAY 2016, DOI: 10.1002/14651858.CD006103.pub7

  2. You have free access to this content
    Pharmacological interventions for smoking cessation: an overview and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Kate Cahill, Sarah Stevens, Rafael Perera and Tim Lancaster

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD009329.pub2

  3. You have free access to this content
    Antidepressants for smoking cessation

    Intervention Review

    The Cochrane Library

    John R Hughes, Lindsay F Stead, Jamie Hartmann-Boyce, Kate Cahill and Tim Lancaster

    Published Online : 8 JAN 2014, DOI: 10.1002/14651858.CD000031.pub4

  4. Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness

    Addiction

    Volume 103, Issue 1, January 2008, Pages: 146–154, John A. Stapleton, Lucy Watson, Lucy I. Spirling, Robert Smith, Andrea Milbrandt, Marina Ratcliffe and Gay Sutherland

    Version of Record online : 19 NOV 2007, DOI: 10.1111/j.1360-0443.2007.02083.x

  5. You have free access to this content
    Interventions for smoking cessation and reduction in individuals with schizophrenia

    Intervention Review

    The Cochrane Library

    Daniel T Tsoi, Mamta Porwal and Angela C Webster

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD007253.pub3

  6. You have free access to this content
    The Effects of Extended Pre-Quit Varenicline Treatment on Smoking Behavior and Short-Term Abstinence: A Randomized Clinical Trial

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 2, February 2012, Pages: 172–180, L W Hawk Jr, R L Ashare, S F Lohnes, N J Schlienz, J D Rhodes, S T Tiffany, J C Gass, K M Cummings and M C Mahoney

    Version of Record online : 30 NOV 2011, DOI: 10.1038/clpt.2011.317

  7. You have full text access to this OnlineOpen article
    Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

    British Journal of Pharmacology

    Volume 171, Issue 14, July 2014, Pages: 3420–3431, A A Feduccia, J A Simms, D Mill, H Y Yi and S E Bartlett

    Version of Record online : 25 JUN 2014, DOI: 10.1111/bph.12690

  8. Prescribing of smoking cessation medication in England since the introduction of varenicline

    Addiction

    Volume 106, Issue 7, July 2011, Pages: 1319–1324, Tessa E. Langley, Yue Huang, Ann McNeill, Tim Coleman, Lisa Szatkowski and Sarah Lewis

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1360-0443.2011.03426.x

  9. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats

    Addiction Biology

    Volume 20, Issue 2, March 2015, Pages: 248–258, Wouter Goutier, Margreet B. Kloeze and Andrew C. McCreary

    Version of Record online : 20 NOV 2013, DOI: 10.1111/adb.12108

  10. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada

    International Journal of Clinical Practice

    Volume 68, Issue 5, May 2014, Pages: 639–646, M. von Wartburg, V. Raymond and P. E. Paradis

    Version of Record online : 29 JAN 2014, DOI: 10.1111/ijcp.12363

  11. Effects of Varenicline on Ethanol-Induced Conditioned Place Preference, Locomotor Stimulation, and Sensitization

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3033–3042, Noah R. Gubner, Carrie S. McKinnon and Tamara J. Phillips

    Version of Record online : 7 JAN 2015, DOI: 10.1111/acer.12588

  12. You have full text access to this OnlineOpen article
    Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline

    Journal of Diabetes Investigation

    Volume 8, Issue 1, January 2017, Pages: 93–100, Serena Tonstad and David Lawrence

    Version of Record online : 14 JUL 2016, DOI: 10.1111/jdi.12543

  13. You have free access to this content
    Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation

    Intervention Review

    The Cochrane Library

    Lindsay F Stead, Priya Koilpillai and Tim Lancaster

    Published Online : 12 OCT 2015, DOI: 10.1002/14651858.CD009670.pub3

  14. Use of stop-smoking medications in the United States before and after the introduction of varenicline

    Addiction

    Volume 110, Issue 2, February 2015, Pages: 346–355, Karin A. Kasza, K. Michael Cummings, Matthew J. Carpenter, Monica E. Cornelius, Andrew J. Hyland and Geoffrey T. Fong

    Version of Record online : 20 NOV 2014, DOI: 10.1111/add.12778

  15. You have free access to this content
    Budgetary Impact of Varenicline in Smoking Cessation in the United Kingdom

    Value in Health

    Volume 12, Issue 1, January/February 2009, Pages: 28–33, Douglas C. A. Taylor, Paula Chu, Virginia M. Rosen, Christine L. Baker and David Thompson

    Version of Record online : 11 JUL 2008, DOI: 10.1111/j.1524-4733.2008.00395.x

  16. You have free access to this content
    Relapse prevention interventions for smoking cessation

    Intervention Review

    The Cochrane Library

    Peter Hajek, Lindsay F Stead, Robert West, Martin Jarvis, Jamie Hartmann-Boyce and Tim Lancaster

    Published Online : 20 AUG 2013, DOI: 10.1002/14651858.CD003999.pub4

  17. Interventions for preventing weight gain after smoking cessation

    Intervention Review

    The Cochrane Library

    Amanda C Farley, Peter Hajek, Deborah Lycett and Paul Aveyard

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD006219.pub3

  18. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation

    Addiction

    Volume 106, Issue 10, October 2011, Pages: 1819–1826, Matthew Taylor, Jo Leonardi-Bee, Shade Agboola, Ann McNeill and Tim Coleman

    Version of Record online : 27 JUL 2011, DOI: 10.1111/j.1360-0443.2011.03493.x

  19. A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities

    Journal of Evaluation in Clinical Practice

    Volume 17, Issue 2, April 2011, Pages: 288–297, Evelina A. Zimovetz, Koo Wilson, Miny Samuel and Stephen M. Beard

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1365-2753.2010.01439.x

  20. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment

    Addiction

    Volume 104, Issue 9, September 2009, Pages: 1597–1602, Peter Hajek, Philip Tønnesen, Carmen Arteaga, Cristina Russ and Serena Tonstad

    Version of Record online : 3 AUG 2009, DOI: 10.1111/j.1360-0443.2009.02646.x